The effects of long-acting methylphenidate on academic activity and related constructs in children with ADHD: A randomised placebo controlled trial
- Conditions
- ADHDhyperkynetic syndrome10037173
- Registration Number
- NL-OMON37537
- Lead Sponsor
- Vrije Universiteit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Patients: Children with ADHD will be included if they (1) are diagnosed with ADHD, (2) are currently treated with methylphenidate to reduce ADHD symptoms, (3) are aged between 8 and 13, (4) have an IQ > 70, and (5) the children and their parents have sufficient knowledge of the Dutch language;Control group: Children will be included if they are (1) aged between 8-13 years, and (2) attend regular primary school
The following exclusion criteria will be applied for the patient group: (1) medication other than methylphenidate, (2) psychiatric disorder(s) other than ADHD and oppositional defiant disorder (ODD) conduct disorder (CD), anxiety disorder and learning disorder and, (3) neurological impairments.;For the control group children will be excluded if they have psychiatric or neurological problems.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method